AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Role of Methotrexate in Ultrasound Proven Synovitis in Primary Knee OA

RecruitingPhase 2Ages 40 Years - 70 YearsAllBangabandhu Sheikh Mujib Medical University, Dhakโ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Background: Osteoarthritis (OA) is a leading cause of disability worldwide, with limited treatment options and many patients suffering from chronic pain. Modern imaging has revealed that OA involves complex changes in cartilage, subchondral bone, and synovium. Pain in OA is often linked to synovitis, which is common in the condition. Methotrexate (MTX), a proven treatment for synovitis in inflammatory arthritis like rheumatoid arthritis and has a well-known safety profile. The proposal suggests that using MTX may have potential to treat symptomatic knee OA with USG (musculoskeletal ultrasound) proven synovitis by reducing synovitis and as a result, alleviate pain. Objectives: To assess the role of methotrexate in primary knee osteoarthritis associated with ultrasound proven synovitis. Methods: This randomized Controlled trial will be conducted in the department of Rheumatology, Bang

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Men and women aged between 40 to 70 years * Patients fulfilling American College of Rheumatology (ACR) clinical and radiological criteria for knee OA. (knee pain + at least 3 of 5 that not including "no palpable warmth") * Knee pain on most days for at least 6 months, with a pain VAS of at least 40mm * Radiological grading of OA with Kallgren-Lawrence grade of 2 to 3 * Patients with the presence of knee synovitis in Musculoskeletal ultrasound Exclusion Criteria: * Any known inflammatory arthritis * BMI \>= 40 kg/m2 * Abnormal renal (e.g. abnormal renal function Creatinine clearance \<35 ml) hepatic (including active hepatitis B, hepatitis C, abnormal liver function), hematological (e.g. white cell count \< 4 ร— 109/L, platelets \<100 ร—109/L, or hemoglobin \< 9 g/dL), function * Use of intra-articular, intramuscular or oral corticosteroids in previous 4 weeks * History knee joint surgery, Charcot joint * Severe valgus knee deformity (angle of genu valgum \> 30ยฐ) * Use of any disease modifying agents (e.g. hydroxychloroquine or sulfasalazine) in previous 3 months * Allergic to MTX * Pregnant or lactating women
๐Ÿ’Š

What it tests

  • Methotrexate (MTX)
  • Placebo
๐Ÿ“

Where

1 site
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Dhaka, Bangladesh
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy